After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.33B. A total of 1.09 million shares were traded on the day, compared to an average of 1.27M shares.
In the most recent transaction, TANG KEVIN bought 500,000 shares of AUPH for 9.09 per share on Dec 09 ’24. After the transaction, the Director now owns 8,429,500 company shares. In a previous transaction on Dec 06 ’24, TANG KEVIN bought 400,000 shares at 9.01 per share. AUPH shares that Director owns now total 7,929,500.
Among the insiders who bought shares, TANG KEVIN acquired of 300,000 shares on Dec 05 ’24 at a per-share price of $8.91. This resulted in the Director holding 7,529,500 shares of AUPH after the transaction. In another insider transaction, Bailey Jeffrey Allen sold 4,557 shares at $8.43 per share on Nov 11 ’24. Company shares held by the Director now total 13,356.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, AUPH has a high of $10.67 and a low of $4.71.
As of this writing, AUPH has an earnings estimate of $0.0 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.16 per share and a lower estimate of -$0.09.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.71, while its Total Shareholder’s Equity was $479.09M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.43.
